MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 118.10M | 113.73M | 98.61M | 88.21M | 92.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 118.10M | 113.73M | 98.61M | 88.21M | 92.91M |
| Cost of Revenue | 19.06M | 18.72M | 18.68M | 16.56M | 16.91M |
| Gross Profit | 99.04M | 95.01M | 79.92M | 71.65M | 76.00M |
| SG&A Expenses | 73.07M | 69.00M | 64.15M | 59.97M | 61.09M |
| Depreciation & Amortization | 129.00K | 112.00K | 100.00K | 99.00K | 193.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.02M | 91.54M | 86.24M | 79.95M | 81.76M |
| Operating Income | 21.08M | 22.19M | 12.37M | 8.25M | 11.15M |
| Income Before Tax | 21.80M | 22.85M | 13.01M | 8.61M | 11.25M |
| Income Tax Expenses | 6.60M | 6.10M | 3.39M | 1.59M | 3.81M |
| Earnings from Continuing Operations | 15.19M | 16.75M | 9.62M | 7.02M | 7.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.19M | 16.75M | 9.62M | 7.02M | 7.44M |
| EBIT | 21.08M | 22.19M | 12.37M | 8.25M | 11.15M |
| EBITDA | 24.30M | 27.48M | 15.51M | 11.48M | 14.14M |
| EPS Basic | 0.10 | 0.11 | 0.07 | 0.05 | 0.05 |
| Normalized Basic EPS | 0.09 | 0.10 | 0.06 | 0.04 | 0.05 |
| EPS Diluted | 0.10 | 0.11 | 0.06 | 0.05 | 0.05 |
| Normalized Diluted EPS | 0.09 | 0.10 | 0.05 | 0.04 | 0.05 |
| Average Basic Shares Outstanding | 148.09M | 148.04M | 147.76M | 147.27M | 147.01M |
| Average Diluted Shares Outstanding | 150.19M | 149.71M | 149.32M | 149.68M | 149.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 2.42% | -- |